Target intelligence / Profile preview

PDCL3 pseudogene 2 (PDCL3P2)

Target
PDCL3P2
Molecular classification
Other, Pseudogene, Retrotransposed pseudogene
01

Overview

PDCL3 pseudogene 2 (PDCL3P2) is a pseudogene derived from the PDCL3 gene, which encodes phosducin-like protein 3, a molecular chaperone involved in G protein signaling, cytoskeletal protein folding, and angiogenesis[1][2][3][4]. Pseudogenes are genomic sequences similar to known genes but typically lack biological function due to mutations or truncations; however, some pseudogenes may act as noncoding RNAs affecting gene expression. Although the PDCL3 gene and other related pseudogenes (such as PDCL3P4) have shown regulatory impact and disease relevance, PDCL3P2 itself is not reported as functional, has no known protein product, and is not considered a therapeutic target. Structured information for PDCL3P2 is largely missing; any functional or clinical relevance remains speculative. PDCL3P2 is not a receptor, enzyme, or transporter, and most pseudogenes, including PDCL3P2, are not protein-coding, though some act via RNA mechanisms. Structured annotation for PDCL3P2 is not available in major genomic databases, and it is not listed among clinically relevant biomarker or drug-interaction targets.

02

Biological functions

Pseudogenes may regulate gene expression via noncoding RNA mechanisms, but no specific function is known for PDCL3P2. For other PDCL3 pseudogenes like PDCL3P4, possible lncRNA activity influencing gene expression was shown.
03

Disease associations

No direct disease association for PDCL3P2 reported. The functional gene PDCL3 is associated with cancer, angiogenesis, and cell cycle regulation.
04

Safety considerations

None known for PDCL3P2
05

Biomarkers

None specific to PDCL3P2. The parent gene PDCL3 is a potential biomarker in some cancers.

Beyond the preview

Go deeper on PDCL3 pseudogene 2 (PDCL3P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PDCL3 pseudogene 2 (PDCL3P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call